Human retinal ganglion cells (RGCs) derived from pluripotent stem cells (PSCs) have anticipated value for human disease study, drug screening, and therapeutic applications; however, their full potential remains underdeveloped. To characterize RGCs in human embryonic stem cell (hESC) derived retinal organoids we examined RGC markers and surface antigen expression and made comparisons to human fetal retina. RGCs in both tissues exhibited CD184 and CD171 expression and distinct expression patterns of the RGC markers BRN3 and RBPMS. The retinal progenitor cells (RPCs) of retinal organoids expressed CD184, consistent with its expression in the neuroblastic layer in fetal retina. In retinal organoids CD184 expression was enhanced in RGC competent RPCs and high CD184 expression was retained on postmitotic RGC precursors; CD171 was detected on maturing RGCs. The differential expression timing of CD184 and CD171 permits identification and enrichment of RGCs from retinal organoids at differing maturation states from committed progenitors to differentiating neurons. These observations will facilitate molecular characterization of PSC-derived RGCs during differentiation, critical knowledge for establishing the veracity of these in vitro produced cells. Furthermore, observations made in the retinal organoid model closely parallel those in human fetal retina further validating use of retinal organoid to model early retinal development.
Introduction
RGCs are neurons that indirectly receive visual information from photoreceptors in the retina. Their axons form the optic nerve that relays this information to the brain's primary vision centers. RGC death is the cause of blindness in two prominent diseases, glaucoma, and optic nerve hypoplasia. Optic nerve hypoplasia is the most common cause of congenital blindness, the etiology of which is unknown and therapy non-existent (Borchert, 2012; GarciaFilion and Borchert, 2013) . Glaucoma is the leading cause of irreversible blindness worldwide, a disease about which much is known but that still lacks a cure (Almasieh et al., 2012; Weinreb et al., 2014) .
Whereas animal models for study of RGC biology and disease have great value, they have limitations and cannot accurately reproduce distinctly human biology (Bouhenni et al., 2012) . Human RGCs derived from PSCs may provide an alternative model to study RGC development and disease. In addition to being human cells, they can be produced with the genetic background of afflicted patients, which can be a uniquely powerful tool for studying human cell biology, disease phenotype, and drug or environmental responses. Additionally the prospect of using PSC derived RGCs for cell replacement therapy is a component of an ultimate curative goal for advanced disease (Cooke and Meyer, 2015; Jayaram et al., 2011; Pearson and Martin, 2015) .
While goals for PSC derived RGCs are lofty, there has been little characterization of the in vitro produced cells. There is a need for rigorous study of molecular and cellular properties of these cells to establish the degree to which they mimic bona fide human embryonic RGCs including their competence to produce the multitude of RGC types observed in adult retina (Sanes and Masland, 2015) . This will define their utility and/or limitations. In this work, we produce RGCs from hESCs in the context of a developing embryonic retinal tissue or retinal organoid. This culture methodology reproducibly produces a significant number of embryonic RGCs in a cellular environment created within the context of a self-forming three-dimensional tissue which replicates many intercellular cell signaling and cell-cell interactions of tissue developing in vivo (Hynds and Giangreco, 2013; Nakano et al., 2012) . We provide an initial characterization of the RGCs produced as well as establish the utility of the surface antigens, CD184 (CXCR4) and CD171 (L1CAM), for RGC isolation.
Materials and methods

hESC culture and differentiation to retinal organoids
All work was performed with Children's Hospital Los Angeles (CHLA) Stem Cell Research Oversight Committee approval. WA09 (WiCell) hESCs were maintained on mouse embryonic fibroblasts in ESCM (DMEM/F12, 20% KSR, 2 mM glutamine, 100 mM NEAA, 100 mM BME, and 4 ng/ml bFGF) and passaged manually following collagenase treatment every four or five days. For production of retinal organoids, WA09 cells were differentiated to neural retina (not optic cup) in three dimensional culture as described (Nakano et al., 2012) except hESC colonies were dissociated with Accutase (Thermo Fisher Scientific) and reaggregated in Lipidure-coated U well 96-well plates (Nof America) using 5000 cells per well in 30 ml Aggrewell media (Stem Cell Technologies) þ 10 mM Y27632 (Tocris).
Media was changed to retinal differentiation media (Nakano et al., 2012) on day 1 and Growth Factor Reduced (GFR) Matrigel (Corning) plus 3 mM IWR1 (Cayman Chemical) were added on day 2.
Matrigel was added to 0.5%; the concentration varied by lot, but this was generally about 50 mg/ml. Tissue was incubated at 37 C, 5% CO 2 , 20% oxygen until use. Usually the entire aggregate formed retinal tissue with the apical surface on the exterior (Fig. 1A) , so an excision step described was unnecessary (Nakano et al., 2012) . We observed some variation in appearance of the differentiated retinal tissue, but all studies were performed with tissue selected for the bright appearance of retinal epithelium (Fig. 1A) .
Fixation and embedding
Retinal organoids were fixed in 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS) at room temperature (RT) for 12e15 min and cryoprotected in 30% sucrose in PBS overnight at 4 C. For embedding, 100 ml OCT Tissue-Tek, spiked with Trypan Blue, was added to the organoids and frozen on dry ice within a larger volume of OCT, the Trypan facilitating visualization of the organoids during sectioning. Cryosections (10 mm) were placed on positively charged slides. Blocks and slides were stored at À80 C. Slides were heated at 37 C for 15 min prior to staining, post fixed 5 min in 4% PFA, and rinsed 3 Â 5 min in TBS þ0.05% Triton X-100 (TBST).
Fetal retina was obtained with approval from the CHLA Institutional Review Board. Eyes were collected in IMDM media and transported on ice. Cornea and lens were removed under a dissecting microscope, with the globe submerged in chilled PBS. The dissected globe was fixed in 4% PFA in PBS for 40 min (pf week 11.5), 25 min (pf week 13), 50 min (pf week 18) at RT followed by 3 PBS washes. Fixed eyes were placed in 30% sucrose in PBS for 15 min on ice and embedded on dry ice in OCT:sucrose (1:2). Cryosectioning and storage were as above for retinal organoids. For staining, slides were thawed at RT for few minutes, post-fixed in freshly prepared 4% PFA for 5 min and rinsed 3 Â 5 min with TBST.
Immunofluorescence
Tissue sections were blocked for 1 h with blocking buffer (5% normal donkey serum and 3% bovine serum albumin (BSA) in TBS with 0.2% Triton X-100) at RT. Sections were incubated with primary antibodies (see Table S1 ) diluted in blocking buffer for 2 h at RT or overnight at 4 C, washed 3 Â 5 min in TBST, incubated with secondary antibodies diluted in blocking buffer for 1 h at RT in the dark, washed 3 Â 5 min in TBST with DAPI (1:1000) included in the last wash, and cover-slipped using Mowial mounting medium plus 
from hESCs undergo mitosis (PH3) at the apical surface (ZO-1) scale bar: 100 mm. C) RPCs give rise to photoreceptors (CRX), horizontal (PROX1), amacrine (AP2a), and bipolar (bright VSX2 day 140, but not day 57) cells. Insets show bright VSX2 signal that co-stains with DAPI while asterisks (*) indicate bright artifacts. Non-specific red (VSX2 day 57) staining is outlined and marked with an asterisk. Scale bar: 100 mm. For immunofluorescent analysis of sorted cells, 5000 cells were centrifuged 400 g 6 min, suspended in 10 ml RDM3-S (DMEM/F12, 10% FBS, 1X N2, 0.5X Glutamax, 0.5 mM retinoic acid, and pennstrep) transferred to poly-L-lysine (SIGMA), GFR Matrigel coated coverslips, allowed to attach at 37 C for 1 h before fixing for 5 min at RT in 4% PFA. Cells were washed 3X with PBS for storage at 4 C and stained as above. Post staining, cells were treated with TrueBlack (Biotium) as per manufacturer's guidelines, and stained with DAPI (1:1000 in PBS) for 5 min after the TrueBlack. For experiments involving EdU, the Click-It kit (Life TechnologiesThermo) staining protocol was followed as specified by the manufacturer. Fluorescence images were acquired with the Nikon Eclipse Ti microscope at 20Â and 10Â magnification. Image intensity was adjusted to present the signal that exceeded most of the background signal in routinely performed IgG controls, except when rabbit antibodies were used, in which case a no primary antibody control was used for background signal adjustment.
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Quantitation of RGCs in retinal organoids
Stained sections to analyze were selected based on the morphology (basal border below the RGC layer and lack of tears or folding of tissue). Single channel images of BRN3 and DAPI were manually globally thresholded in ImageJ to include all positive cells and minimal noise and background. To avoid inaccuracies associated with identifying closely packed individual cells the total thresholded area was recorded as a measurement proportional to cell number. The ratios of the BRN3 area (RGCs) to DAPI area (total cells) were computed for normalization.
Axon outgrowth
GFR Matrigel was diluted 3-fold with RDM3-S and 1 ml used to coat a 35 mm tissue culture dish which was incubated at 37 C for 30 min to create a thin, firm gel. Three retinal organoids cultured to the indicated day and 1 ml of RDM3-S were added on top of each gel. The retinal organoids were allowed to adhere to the gel and project neurites. Phase-contrast images were taken after 5 days of growth at 37 C, 5% CO2.
Flow cytometry
Retinal organoids of specified age were washed with HBSS and dissociated for 30 min at 37 C with Accutase (200 ml/sphere) with intermittent trituration. Cells were pelleted at 400 g 6 min, resuspended in RDM3-S media, treated with DNase (100U/ml) for 15 min at RT, pelleted again and resuspended in BD block solution such that after subsequent antibody addition there were 10^4 cells/ml. Antibodies were used at recommended dilutions (Table S1 ) and incubated for 45 min to one hour at 4 C in the dark. After washing with BD block solution, the cells were resuspended in 5% FBS, PBS containing DAPI, placed on ice, and analyzed on a BD FACSCanto II or BD LSR II, or sorted on a BD FACSARIA into RDM3-S on ice. FACs DIVA software analysis of single color labeled beads was used to set compensation for all flow experiments except no compensation was performed for those using only PE, APC and DAPI. Doublets were eliminated on FCS-H vs FCS-W and SSC-H vs SSC-W plots and DAPI positive cells were excluded from all data shown or prior to sorting. "All cells" or "total cells" refers to the population of DAPI negative cells collected for analysis independent of surface marker characteristics. For experiments analyzing fixed cells by flow cytometry, cells were processed and stained with surface antigens as above, fixed in 4% PFA in PBS for 15 min RT, washed 2X with PBS, permeabilized with 90% methanol for 30 min at 4 C in the dark, washed 2X with 1% BSA in PBS (BSA/PBS), incubated with primary antibody diluted in BSA/PBS for 30 min RT in the dark, washed 2X in BSA/PBS, incubated in secondary antibody 30 min RT in the dark, washed 2X in BSA/PBS, and suspended in BSA/PBS for flow cytometry analysis. After the fixation step, cells were pelleted at 3000 g for 5 min. When EdU detection was required the cells were processed as above except that 0.5% Triton in PBS for 15 min at RT was used for permeabilization and the Click-IT reaction was carried out as specified by instructions (Thermo Fisher Scientific) following permeabilization. Where noted, Zombie NIR (Biolegend) was used to eliminate dead cells and used according to the manufacturer's instructions prior to surface antigen antibody incubation.
Quantification of sorted single cells
Single cell images had their channels separated and converted into .tiff files. Using ImageJ, background subtraction with a rolling ball radius of 50 was performed on all channels. Then the DAPI channel was manually thresholded so that only the nuclei were highlighted. Channels other than DAPI were specified to be measured in the analysis. ImageJ's Analyze Particle function was then used to measure mean grey values (MGVs) of the specified channels for particles larger than 25 mm 2 highlighted by the DAPI threshold. The tabulated MGVs for each condition were binned, and a cutoff determined as one greater than the highest MGV positive bin in the experiment controls. The percentage of cells above the MGV cutoff was used as an indicator for percentage of positive signal. For goat and mouse antibodies a concentration matched species specific IgG was used for the control. For rabbit antibodies no primary antibody was used as the control.
RT-qPCR
For RT-qPCR, RNA was extracted from 5000 or 10,000 sorted cells using a PicoPure RNA Isolation kit (Thermo Fisher Scientific) -including the DNase digestion step-and cDNA generated with Superscript III (Thermo Fisher Scientific) according to instructions. Realtime PCR reactions utilized primers and hydrolysis probes (Table S2) , Taqman Universal Mastermix II (Thermo Fisher Scientific) and an Applied Biosystems 7900HT realtime PCR machine.
Non template controls were performed in parallel. 10 ml assays were performed in triplicate and DDCt calculated relative to the total population of live cells using GAPDH as a reference gene, except for Fig. S2E where UBC served as the reference. Error is the propagated standard deviation of triplicate measures.
Results
Basic properties of RGCs produced in retinal organoid culture
Retinal organoids were produced from hESCs using a differentiation protocol similar to that developed in the Sasai laboratory (Nakano et al., 2012) . RPCs developed in a polarized epithelium within two and a half to three weeks of differentiation giving rise to RGCs beginning week three to four, followed by horizontal, photoreceptor, amacrine, bipolar, and Mueller glial cells in subsequent weeks (Figs. 1 and 2 and data not shown).
To characterize RGCs in the retinal organoids we evaluated expression of the common molecular markers ATOH7 (MATH5), which identifies RGC competent RPCs as well as early post-mitotic RGCs, and BRN3 (BRN3a-c, POU4f1-3), which is a family of transcription factors required for RGC differentiation ( Fig. 2A) (Brown et al., 2001; Mu et al., 2005; Wang et al., 2001; Xiang et al., 2011; Yang et al., 2003) . In retinal organoids ATOH7þ cells were first detected by day 27 and observed interspersed in the neuroblastic layer (NBL) as retinal organoids mature. They were also apparent in an emerging basal layer. The ATOH7þ cell population overlaps with BRN3þ cells that were also primarily observed in the emergent basal layer. This pattern is expected of ATOH7þ RPCs that mature first to BRN3þ ATOH7þ RGC precursors, and then to BRN3þ, ATOH7-RGCs (Fu et al., 2009; Xiang et al., 2011) .
The number of BRN3þ RGCs increased until roughly day 50 and then exhibited a slow decline ( Fig. 2A and B) . Axonogenesis (TAU staining) from BRN3þ cells was observed in retinal organoids, and when provided a Matrigel substrate retinal organoid derived axons exhibited competence for robust extension ( Fig. 2C and D) . No axon demonstrating axon outgrowth from a day 51 retinal organoid placed on Matrigel, but not from day 23 or 114 retinal organoids, prior to RGC genesis or after RGC death, respectively.
Scale bar: 500 mm. Axon branching and growth cones at day 51 are shown at higher magnification. Scale bar: 100 mm.
outgrowth was observed at ages prior to RGC production (day 23) or after RGC death (day 114) consistent with a RGC origin of these axons (Fig. 2D) .
We also examined expression of RBPMS, an RNA binding protein thought to be expressed in all RGCs of vertebrates (H€ ornberg et al., 2013; Kwong et al., 2010; Rodriguez et al., 2014) . In retinal organoids BRN3þ cells were abundant at day 27 while RBPMSþ cells were rare; however, RBPMS cells became abundant at later ages, consistent with BRN3 being a transcription factor required early to specify RGC development and RBPMS functioning in a differentiating cell (H€ ornberg et al., 2013; Mu et al., 2005; Xiang et al., 2011) (Fig. 3A) . Interestingly, in retinal organoids relatively few cells appeared to co-stain for BRN3 and RBPMS; however, upon close inspection in all RBPMSþ cells BRN3 signal was detected, albeit weakly compared to many BRN3þ cells. The opposite was not true in that not all BRN3þ cells expressed a detectable level of RBPMS (Fig. 3A) . This pattern of RBPMS-BRN3þ, RBPMSþ BRN3þ, or RBPMSþ BRN3 weak was observed in human fetal retina at postfertilization (pf) week 13 as well (Fig. 3B) . Also apparent in fetal retina was that the relative expression patterns of RBPMS and BRN3 were not uniform across the developing retina, with BRN3 predominant in central, more mature, cone-rich retina and RBPMS more dominant in the less mature, rod-rich periphery.
The results show that RGCs in retinal organoids are derived from ATOH7 competent progenitors, migrate to the basal layer of the retina, form distinct BRN3 and RBPMS expressing embryonic populations, and exhibit a robust competency to produce and extend axons; thus demonstrating that RGCs in hESC-derived retinal tissue share basic characteristics with RGCs in vitro.
CD184 and CD171 identify RGCs at differing stages of maturation in retinal organoid culture
An ability to isolate retinal organoid RGCs facilitates a more rigorous molecular characterization. Accordingly, we examined expression of CD90 (Thy-1), which has proven useful for RGC purification in rodent retina (Barnstable and Dr€ ager, 1984; Barres et al., 1988) . In human fetal retina, CD90 was detected in a pattern consistent with expression in maturing RGC processes: strong signal in the RGC nerve fiber layer (NFL) and weaker signal in the inner plexiform layer (IPL) (Fig. S1A) . However, immunostaining and flow cytometry of CD90 expression in retinal organoids was not consistent with expression solely on RGCs since CD90 expression was fluid through time, and persisted after the time when most RGCs have died (day 93) (Fig. S1B, Fig. 2B) . A subset of cells, however, exhibited relatively high CD90 expression at days 34, 42 and 48, when RGCs were prevalent (Fig. S1B) . A small subset of these expressed BRN3B as expected of RGCs, but the majority expressed VSX2 and NES suggesting that they may be a subset of RPCs (Fig. S2) . Thus, CD90 expression appears to be confined to RGCs in fetal retina, but not in retinal organoids.
As CD90 did not clearly identify RGCs in hESC-derived tissue, the utility of other surface proteins that have reported expression in RGCs in mouse, chick, or zebrafish, namely CD171 (L1CAM), and CD184 (CXCR4), was investigated (Bartsch et al., 1989; Chalasani et al., 2003; Demyanenko and Maness, 2003; Q. Li et al., 2005; Lyckman et al., 2000; Pujic et al., 2006) . The patterns of both CD171 and CD184 staining in retinal organoids were consistent with RGC expression (Fig. 4 and Fig. S4 ). The onset of signal coincided roughly with the onset of RGC production, day 27, and signal was observed in the basal layer where RGCs were located (Fig. 4A compared to Fig. 2A ). While both antigens were detected at day 27, CD171 appeared weak compared to CD184, while by day 34 the two surface markers had a similar intensity. This suggests that CD184 expression precedes that of CD171. CD171, similar to TAU, was detected on processes traversing the basal to apical dimension of the retinal organoids (for example Fig. 2C , day 57 Fig. 4A and days 36 and 41 Fig. S4 ). In addition, both CD171 and TAU were detected at the apical surface of retinal organoids (Figs. 2C and 4A day 34e61 and Fig. S4 d41-76 ). This detection of CD171 expression on the apical surface of the retinal organoids, is thus consistent with its well-documented expression on RGC axons (Demyanenko and Maness, 2003; Lyckman et al., 2000) . Notably the CD171 surface signal diminished along with the basal signal with timing consistent with rapid death of RGCs (day 97). In contrast, the CD184 staining in retinal organoids persisted through day 97 (Fig. 4A) ; however, detection of CD184 at this age varied which may be due to the presence or absence of RGCs at a culture period when they were rapidly dying (Fig. 2B, data not shown) .
Examination of CD184 and CD171 expression in retinal organoids in flow cytometry time courses suggest that most cells acquire a weak CD184 expression around day 20 since in one experiment the majority of cells are unlabeled (Fig. S3 ) and in a second experiment the majority of cells are labeled (Fig. 4B) . If one assumes different preps exhibit some variability in maturity, then this is consistent with day 20 being an approximate time when the cell population is in transition from non-expressing to weakly expressing CD184. A subset of the retinal organoid cells acquired stronger CD184 (CD184hi) immunoreactivity by day 26, a population of cells which peaked at day 34e40 and then declined (Fig. 4B and Fig. S3 ). Few cells exhibited CD171 expression on day 26, but that number continued to increase throughout the time course and the proportion of cells exhibiting a CD184hi CD171þ phenotype increased as retinal organoids mature (Fig. 4B and Fig. S3 ). Both the flow cytometry and immunostaining data suggests that CD184 expression precedes that of CD171.
Expression of CD184 and CD171 was also examined in human fetal retina. Both CD184 and CD171 were clearly seen in the NFL on the axons below the ganglion cell layer (GCL) at pf weeks 11.5 and 13 although not in precisely the same pattern ( Fig. 4C and Fig. S5 ). CD171 exhibited strong expression on axons in the relatively mature central retina and those exiting the optic nerve head, with somewhat lower expression in the less mature nasal peripheral region at both ages. Also there was a notable absence of or weak CD171 expression in ganglion cells axons in the central/foveal region, yet there were clearly BRN3þ cells present (Fig. S5 ). This suggests that central/foveal RGCs either do not express CD171 or do so with a differential timing.
CD184 was detected in pf weeks 11.5 and 13 as well. At pf week 11.5 CD184 was primarily detected in the NFL; however, in the nasal peripheral region expression appeared to pervade the emerging RGC layer consistent with localization to migrating cell bodies and neurites of migrating RGCs (Fig. 4C) . At the later developmental stage of pf week 13, CD184 expression was more ubiquitous, observed in the NFL, the RGC cell bodies, emerging IPL, as well as in the NBL and emerging ONL (Fig. 4C) . Like CD171, expression appeared absent from the central/foveal retina at these ages. In addition to being detected on cell types other than RGCs, CD184 expression appeared dynamic in RGC axons, very bright on GC axons at exiting the optic nerve at pf week 11.5, but largely disappearing by pf week 13, suggesting transient CD184 expression in RGC axons.
Comparing the most peripheral expression at pf week 11.5, CD184 appears to precede CD171 expression (Fig. 4) . Overall, subtleties in the expression patterns of CD171 and CD184 suggest that surface marker expression exhibits a complexity in the developing fetal retina that will require a more extensive analysis to document precisely, but indicate a specificity to RGC neurites for CD171 and suggests a transient expression in RGCs for CD184.
The expression in the RGC layer of both fetal and hESC-derived retina suggested that sorting of the CD184hi cells and/or the CD184hi CD171þ cells could be useful for RGC isolation. To test this idea dissociated retinal organoid cells were fixed, coimmunolabeled for CD171, CD184 and BRN3 and analyzed by flow cytometry. BRNþ cells comprised about 7% of the total cells after 35 days of differentiation and most expressed CD184 or CD184 and CD171 (Fig. 5A ). BRN3þ cells were most enriched when limiting selection to the highest CD184 expression (Fig. 5B and C) . Sorting of live cells from the hESC derived retinal tissue at differentiation day 33 demonstrated that about 75% of cells exhibited BRN3 expression in a CD184hi CD171þ fraction and about 40% in a CD184hi fraction (Fig. 5D, E and F) . Since BRN3-cells were present in a CD184hi CD171þ fraction we addressed the possibility that these cells expressed BRN3 weakly but might have strong RBPMS expression as was observed for a subset of RGCs by immunostaining ( Fig. 2A) . Therefore, in a similar cell sorting experiment, cells were stained for RBPMS in addition to BRN3. Most RBPMSþ cells were also BRN3þ, but RBPMS þ cells BRN3-cells comprised only an additional 5% of the cells, meaning that the precise nature of the remaining BRN3-RPBMS-cells remains unclear (data not shown).
Enrichment for RGCs was also seen by RT-qPCR since BRN3B transcripts were enhanced in both CD184hi and CD184hi CD171þ fractions, but not CD171þ fractions (Fig. 5G and Fig. S6 ). Genes identifying RPCs (VSX2 and NES) were relatively depleted in the RGC enriched fractions (CD184hi and CD184hi CD171þ) suggesting a reduction in the percent of RPCs, the cells that dominate the retinal organoids at this age. ATOH7, required for RGC formation but not expressed in mature RGCs, was enriched primarily in the CD184hi fraction. EYA2, which is thought, along with BRN3B, to be a direct target of ATOH7, was detected in both CD184hi and CD184hi CD171þ fractions (Gao et al., 2014; Hutcheson and Vetter, 2001 ). Other genes expressed in RGCs including ISL1, EBF3, MYT1 and GAP43 were concentrated primarily in the CD184hi CD171þ fraction. EBF3 and GAP43 are expressed in a more mature, Fig. 4 . Expression of surface markers CD184 and CD171 in hESC-derived and human fetal retina. A) Developmental time course of hESC-derived retina immunostained with anti-CD171-PE (Life Technologies) and anti-CD184-PE. DAPI is blue. With the CD184 antibody areas of non-specific staining or probable non specificity are outlined and marked with an asterisk. An independent CD171 antibody showed similar staining pattern (Fig. S4) . Scale bar: 100 mm. B) Flow cytometry plots of dissociated retinal organoid cells of the indicated age labeled with anti-CD184-APC and anti-CD171-PE. Each plot shows data comprised of cells from six dissociated retinal organoids. Quadrant lines drawn based on unstained cell or IgG control signal (both exhibited equivalent signal), while boxes gate the CD184hi or CD184hi CD171þ populations with percent of total cells shown within. CD184hi is discriminated from CD184þ based on a visual assessment of the minor population exhibiting higher levels of CD184. C) Immunostaining of pf weeks 11.5 and 13 human fetal retina. Noncontiguous pictures show the progression from nasal to temporal retina with cartoon showing approximate picture location in the retina. Insets show either cells from the GCL(a) or NBL(b) at 3.5X ONH (optic nerve head). At pf 13 inset b includes part of the emerging ONL as well. Staining (including that in Fig. S5 which shows BRN3 detection for reference) was performed on adjacent retina sections, each stained with different antibodies. For each antibody all pictures were taken from the same section with identical exposure times. The only exception is the pf 11.5 central picture (temporal to the ONH) because the ONH was not found in the same section as the most central retina stained. Scale bar: 250 mm.
differentiating RGCs and, in the human retina, ISL1 expression is detected subsequent to BRN3 (Pacal and Bremner, 2014) . Thus, the pattern of enrichment of all of these genes suggests that the CD184hi CD171þ fraction contains more mature BRN3þ RGCs than the CD184hi fraction.
To further evaluate whether CD184hi cells are less mature than the RGCs in the CD184hi CD171þ fraction, we performed EdU pulse-chase experiments designed to observe progression of immature, but postmitotic RGCs to more differentiated RGCs (Fig. 6) . Intact retinal organoids were labeled with a 10 h EdU pulse in order to label a large number of proliferating RPCs, followed by a relatively short (14 h) and long (4 day) label-free chase. Some of the RPCs (EdUþ CD184þ) were assumed to exit the cell cycle during the chase period and enhance expression of CD184 and CD171 to become EdUþ CD184hi or EdUþ CD184hi CD171þ cells. If after leaving the cell cycle, EdUþ cells first express high CD184 (but not CD171), and subsequently, as cells mature, CD171 is expressed, then after the "short" chase (14 h) more EdUþ cells would be present in the CD184hi fraction than the CD184hi CD171þ fraction. However, after the "long" chase (4 days), the EdUþ cells would be expected to distribute in both fractions with fewer EdUþ cells in the CD184hi fraction compared to CD184hi CD171þ fraction, as they would have matured to populate the CD184hi CD171þ fraction. Alternatively, if there were no difference in expression timing of CD184 and CD171 then similar numbers of EdUþ cells in the different sorted fractions would be expected. The results showed that after a 14 h chase about 30% of BRN3þ cells in the CD184hi population were EdUþ, whereas only 5% of BRN3 þ cells were EdUþ in the CD184hi CD171þ population (Fig. 6D) . After a 4 day chase the percent of BRN3þ and EdUþ cells in the CD184 hi fraction had dropped to 17% while in the CD184hi CD171þ population the percent of BRN3þ and EdUþ cells increased to 36% (Fig. 6D ). This data is consistent with newly post mitotic CD184hi BRN3þ RGCs maturing to express CD171.
RPCs in retinal organoids were expressing CD184 around day 20 in culture ( Fig. 4B and Fig. S3 ), and by day 26 some cells expressed a higher level of CD184 (Fig. 4B and Fig. S3 ). We wondered whether the high CD184 expression is a property only of post-mitotic cells or alternatively, whether at least some of these cells remain in the cell cycle. To address this, retinal organoids were subjected to a 1 h EdU pulse to label only cells in S-phase, then co-labeled with CD184, CD171, and ATOH7 or PH3 and analyzed by flow cytometry. About 26% of the CD184hi cells were labeled by EdU, and hence in S-phase, and about 5% were in mitosis (PH3þ) (Fig. 7A and B) , demonstrating that a significant fraction of CD184hi cells had not yet exited the cell cycle. In addition, 20% of the CD184hi ATOH7þ cells were EdUþ, similar to the 25% percent Atoh7 expressing RPCs reported to be actively proliferating in the mouse retina (Fig. 7B) (Kiyama et al., 2011) . This data indicates that many RPCs expressing ATOH7, or those RPCs competent to become RGCs, also expressed the higher level of CD184. Also, RT-qPCR analysis of the CD184hi fraction of sorted cells showed an enrichment for several factors, FOXN4, PROX1, NEUROD1, NEUROD4(MATH3), in addition to ATOH7, that are known to be expressed as RPCs acquire competence for generating amacrine, horizontal, and photoreceptor cells, and transition toward cell cycle exit (Akagi et al., 2004; Boije et al., 2013; Dyer et al., 2003; Fujitani et al., 2006; Inoue et al., 2002; Li et al., 2004; Mao et al., 2008 Mao et al., , 2013 Xiang and Li, 2013) (Fig. 7C ). Together these data raise the possibility that as some RPCs move toward cell cycle exit or neurogenic divisions to generate RGCs, and possibly other cell types, they boost CD184 expression to higher levels. This is consistent with the observed CD184 staining of the NBL in fetal retina, although the fetal staining varies with intensity depending upon age or location within the developing retina suggestive of an unresolved complexity (Fig. 4) . Overall, the data suggests that RPCs in retinal organoids acquire a low level CD184 expression around day 20, then roughly coincident with an RPCs' acquisition of ATOH7 expression, or competence to differentiate to RGCs, it enhances CD184 expression prior to exiting the cell cycle.
Discussion
In this work we characterized basic properties of hESC-derived RGCs as well as demonstrated that antibodies to CD184 and CD171 could be used to identify maturation stages of hESC-derived RGCs from committed progenitors to post-mitotic maturing RGC precursors.
Human retinal ganglion cell characterization
RGCs have been identified in retinal organoids by expression of BRN3 (Nakano et al., 2012; Phillips et al., 2012; Zhong et al., 2014) , and axons attributed to organoid RGCs are capable of producing sodium-dependent action potentials as well as microtubule dependent antero-and retrograde transport (Maekawa et al., 2015; Tanaka et al., 2015) . However, RGCs in this system otherwise remain uncharacterized. Here we demonstrated that several properties of RGCs in organoids are similar to RGCs in vivo. 1) As anticipated of bona fide RGCs, the data suggested that retinal organoid RGCs were generated from ATOH7þ RPCs, that mature into BRN3þATOH7-RGC cell precursors. 2) In human RGCs, BRN3 expression preceded that of ISL (Pacal and Bremner, 2014) , whereas in the mouse where these genes were expressed co-temporally (Mu et al., 2008; Rachel et al., 2002) . The human organoid RGCs reproduced the human pattern. 3) hESC-derived RGCs, like human fetal RGCs expressed RBPMS in a subset of BRN3þ cells, and many of the RBPMSþ cells expressed BRN3 relatively weakly. 4) Developing human RGCs in both retinal organoid and fetal tissue expressed CD184 and CD171. 5) CD184 was expressed on organoid RGCs with a timing that temporarily preceded CD171, an observation made in the retinal organoids, but consistent with the staining pattern observed in fetal retina. 6) BRN3 enriched populations in retinal organoids were shown to express genes previously identified in mammalian RGC precursors (PAX6, ATOH7, EYA2, MYT1) and differentiating RGCs (EBF3, GAP43) (Gao et al., 2014; Mu et al., 2005) . 7) The production of axons from retinal organoid retinal ganglion cells reported here and by others (Maekawa et al., 2015; Tanaka et al., 2015) suggests that the retinal organoid environment is providing appropriate factors to induce axon outgrowth, a process which does not occur by default but rather requires trophic signaling and is enhanced by electrical activity (Goldberg et al., 2002) . These data, and the fact that some of our observations (numbers 3, 4,and 5 above) were first made in in vitro in retinal organoids and subsequently confirmed in fetal retina, serves to extend the current morphological and cell marker evidence (Meyer et al., 2011; Nakano et al., 2012; Zhong et al., 2014) documenting the validity of employing retinal organoids as an experimental model to study early human retinal development.
This work however also served to uncover some deviations from normal developmental processes. Extension of nascent axons to the apical surface (Fig. 2C) suggests RGC polarize improperly since axons normally extend basally to the inner limiting membrane. In zebrafish, RGC polarization occurs shortly after cell cycle exit and depends on extrinsic signals, such as laminin in the inner limiting membrane (Randlett et al., 2011; Zolessi et al., 2006) . That the lens and ciliary body synthesize proteins comprising this basement membrane (Halfter et al., 2008 (Halfter et al., , 2005 but these structures are absent in the organoid cultures perhaps offers an explanation for this result. The death of all RGCs within a couple months also does not normally occur in vivo. The organoid RGC axons lack not only a proper inner limiting membrane, but also the optic nerve head, optic track and appropriate neuronal targets. This raises the possibility that the observed decrease in RGC number may be analogous to RGC apoptosis that occurs in vivo when RGCs are unable to innervate appropriate targets (B€ ahr, 2000; Isenmann et al., 2003; Provis, 1987; Provis and Penfold, 1988) . We also observed aberrant CD90 expression as it was not restricted to RGCs as it largely appears to be in the human fetal retina. This may be an artifact of in vitro culture. These observations define some limitations of the organoid system which could be targeted with culture refinements to enhance the value as a model system. This work revealed several other potentially interesting observations of developing human RGCs that will require further study to validate functional relevance. The expression patterns of BRN3 and RBPMS in pf week 13 fetal retina elucidated distinct RGC populations during development: RBPMS-BRN3þ, RBPMSþ BRN3þ, or RBPMSþ BRN3 weak cells. This could be representative of different states of maturation, which based on expression timing observed in organoids, is predicted to progress from immature RBPMS-BRN3þ cells to more mature RBPMSþ BRN3 weak cells. However, the distribution in the fetal retina, where the less mature retina in the rod rich periphery is heavily populated by the RBPMSþ BRN3 weak cells, whereas the more mature cone rich central retina is enriched in the RBPMS-BRN3þ cells, argues against a developmental progression and raises the possibility that these markers distinguish distinct developmental paths that early human RGCs follow en route to diversification to their many types. In contrast, in adult rodent retina RBPMS is thought to be universally detected in RGCs (Piri Gates were selected to maximize the percent of RGCs based on data in B and C. E) Immunodetection of BRN3þ cells in sorted cell population is shown as average ± SD from 3 (or 2*) coverslips. The total number of cells analyzed to generate the data is indicated. F) Representative images used to generate the graphed data in E. * artifact excluded from analysis. G) RT-qPCR analysis of sorted cells relative to total cells. Those samples where average Ct values were greater than 37 are marked (*) since this is near the limit of detection and contributes to large errors for some samples, especially when the gene is weakly expressed in the total cell population. Qualitatively similar data was obtained in four similar experiments, two of which are shown in Fig. S6 . Rodriguez et al., 2014) . This difference could be due to the maturity of RGCs (embryonic versus adult) or species differences.
Additionally, CD171 was readily detected in the human fetal retina on RGC neurites at pf weeks 11.5 and 13 as was expected given that CD171 (L1CAM) is implicated in axon guidance or targeting functions of at least some RGCs (Buhusi et al., 2008; Demyanenko and Maness, 2003; Feldheim and O'Leary, 2010) . However, CD171 staining was absent in the central/foveal region implying that these RGCs do not utilize CD171 for axon biology, at least at these developmental stages.
CD184 staining of the fetal retina is also interesting since it's expression appears transient in RGC axons as it is readily detected on fibers exiting the optic nerve head at pf 11.5, but only a very modest expression is seen at pf 13 on optic nerve head fibers. This may be analogous to a brief period of CD184 expression during RGC differentiation that has been described in zebrafish (Pujic et al., 2006) . Transient expression may explain the absence in the relatively mature central/foveal at the ages examined.
Expression of CD184 and CD171 on human retinal organoid RGCs
This work demonstrated that the timing of CD184 and CD171 expression in differentiating retinal organoids was concurrent with RGC production and maturation and showed that high levels of CD184 expression were characteristic of RGC competent progenitors and early post-mitotic cells, while maturing RGCs maintained CD184 expression but also expressed CD171. This conclusion is supported by the detection of ATOH7þ cells in S-phase in CD184hi fractions, the appearance of CD184hi expression chronologically prior to CD171, the disappearance of CD184hi cells and appearance of greater number of dual positive cells through time, and the detection of pulsed-chased EdU in the CD184hi population prior to the CD184hi CD171þ cells. There also was a lack of enrichment of genes associated with RGC differentiation in the CD184hi cells, whereas these cells showed greater enrichment for ATOH7 which is only transiently expressed in developing RGCs.
The data discussed above demonstrated that CD184 and CD171 were expressed on RGCs in retinal organoids and thus enables employment of these surface markers to obtain a cell population enriched for RGCs or RGC precursors. However, there were BRN3-and RBPMS-immunonegative cells present in sorted fractions. This suggests that CD184hi and CD184hi CD171þ sorted fractions may also contain other cell types. As suggested by expression of FOXN4, PROX1, NEUROD1, and NEUROD4 in Fig. 7C , the CD184hi fraction, in addition to RGC competent progenitors and RGC precursors, may contain RPCs competent to become amacrine, horizontal, and/or photoreceptor cells. Furthermore ATOH7 expressing progenitors do not exclusively develop into RGCs, as lineage tracing of ATOH7þ cells revealed that many ATOH7þ cells become amacrine cells, horizontal cells, and rod and cone photoreceptors (Brzezinski et al., 2012; Feng et al., 2010) . Thus, it will be interesting in future studies to understand the nature of all the cells in the CD184hi population especially given the heterogeneous character of RPCs and probabilistic decisions associated with RPC cell fate commitment (Boije et al., 2014; Cepko, 2014; Kiyama et al., 2011; Trimarchi et al., 2008) . The CD184hi CD171þ fraction showed variable enrichment of transcripts for inner neurons (TFAB2B, PTF1A, LIM1, PROX1) and photoreceptors (CRX) suggesting that photoreceptors, horizontal and amacrine cells can be present (Fig. 5G and Fig. S5) . Notably the relative level of these transcripts was reduced when the gate used for sorting was more restricted to include only the highest CD184 expressing cells (compare Fig. S6A to Fig. 4D and G and Fig. S6B ), consistent with the data showing BRN3þ cells were most enriched when limiting selection to the highest CD184 expression (Fig. 5B  and C) . The data is consistent with a fraction of the non BRN3þ cells being photoreceptors, amacrine cells, or horizontal cells. Thus, this work demonstrates that CD171 and CD184 permit significant enrichment of differentiating RGCs from retinal organoids, but not isolation to purity unless detection of other cell type transcripts is not associated with translation into proteins or is a reflection of plasticity and heterogeneity at this early stage in development (Trimarchi et al., 2008 (Trimarchi et al., , 2007 .
In conclusion, CD184 and CCD171, by enabling enrichment of RGCs at different stages of maturation, should be useful tools for further characterization of human retinal organoid RGCs.
